Operationally, Noxopharm has approximately three quarters of operating cash flows remaining, based on current cash holdings and a forecast operating cash outflow of circa$1.35m per quarter moving forward.
The company continues to be vigilant with its cash resources and is exploring a range ofoptions in relation to securing additional capital. It is looking at its strategic plan and exploringthe likelihood of short-term catalysts which may impact the timing and range of options tosecure follow-on funding.
CR before year end?
NOX Price at posting:
6.0¢ Sentiment: None Disclosure: Not Held
